AIM2 expression is upregulated in infected cells, and knockdown of AIM2 attenuates IL-1β release (Torii et al., 2017), indicating that AIM2-dependent activation of the inflammasome is triggered by EBV infection. The gene discussed is IL1B; the disease is Epstein-Barr virus infection.